Evidence map›Paper›PMID 29850563›Full record

ArticleBioMed research international2018

A Novel Heterozygous Missense Mutation in

Christina Zeitz, Cécile Méjécase, Mathilde Stévenard, Christelle Michiels, Isabelle Audo, Michael F Marmor

Open access · hybridAbstract readCase Reports
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Christina ZeitzSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.ORCID 0000-0002-3510-1712
Cécile MéjécaseSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.ORCID 0000-0003-2532-4004
Mathilde StévenardSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Christelle MichielsSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
Isabelle AudoSorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.ORCID 0000-0003-0698-5309
Michael F MarmorDepartment of Ophthalmology and Byers Eye Institute, Stanford University School of Medicine, Palo Alto, CA, USA.ORCID 0000-0001-6057-440X
Centre National de la Recherche Scientifique · FRStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant congenital stationary night blindness (adCSNB) is rare and results from altered phototransduction giving a Riggs type of electroretinogram (ERG) with loss of the rod a-wave and small b-waves. These patients usually have normal vision in light. Only few mutations in genes coding for proteins of the phototransduction cascade lead to this condition; most of these gene defects cause progressive rod-cone dystrophy. Mutation analysis of an adCSNB family with a Riggs-type ERG revealed a novel variant (c.155T>A p.Ile52Asn) in

Indexed as

AdultEye Diseases, HereditaryFemaleGenetic Diseases, X-LinkedHeterotrimeric GTP-Binding ProteinsHeterozygoteHumansMaleMutation, MissenseMyopiaNight BlindnessTransducinYoung AdultGNAT1 protein, humanHeterotrimeric GTP-Binding ProteinsTransducin

Identifiers

PMID29850563
PMCPMC5937575
OpenAlexW2800352544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.